Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending September 26, 2013. The report details a specific share repurchase transaction executed under shareholder authority granted at the Annual General Meeting on May 1, 2013.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on capital structure and share buyback activity.
- Shares Purchased: 1,515,000 Ordinary Shares of 25 pence each.
- Price Range: Highest price paid was 1,602.50 pence per share; lowest price paid was 1,592 pence per share.
- Treasury Holdings (Settled): 476,664,412 shares (8.88% of total issued share capital).
- Treasury Holdings (Including Unsettled): 481,189,412 shares (9.84% of current total voting rights).
- Shares in Issue (Excluding Treasury): 4,888,652,429 shares.
Material Changes
The primary material change reported is the reduction of outstanding shares through the purchase of 1,515,000 shares on September 26, 2013. Consequently, the percentage of shares held in Treasury increased to 8.88% of issued capital and 9.84% of total voting rights when including unsettled transactions.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a compliance announcement confirming conformity with the Financial Conduct Authority's Disclosure and Transparency Rules and explicitly states it does not constitute an offer to purchase securities.
Investor Verification Checklist
- Verify the total number of shares held in Treasury (476,664,412 settled) against the company's latest capitalization table.
- Confirm the calculation of voting rights (9.84%) including unsettled shares for disclosure threshold assessments.
- Check the remaining authorization for share buybacks under the mandate granted on May 1, 2013.
- Review the Financial Conduct Authority's Disclosure and Transparency Rules to ensure shareholder notification thresholds are correctly applied using the 4,888,652,429 shares in issue as the denominator.